Repligen Corp SEC filings RGEN

Repligen Corp has 1,003 filings in SEC EDGAR's recent list, going back to May 13, 2010. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (unregistered share sale, other events). The company's fiscal year ends on December 31.

Repligen Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 30, 2026 Sep 30, 2026
8-K Current report
Unregistered share sale, Other events
Oct 30, 2026 Oct 29, 2026
8-K Current report
Results of operations
Oct 27, 2026 Oct 27, 2026
4 Insider transaction Oct 8, 2026 Oct 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 7, 2026 —
4 Insider transaction Oct 6, 2026 Oct 5, 2026
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Oct 6, 2026 Oct 6, 2026
144 Notice of proposed sale Oct 5, 2026 —
4 Insider transaction Oct 5, 2026 Oct 2, 2026
144 Notice of proposed sale Oct 5, 2026 —
425 Filing Sep 30, 2026 —
4 Insider transaction Sep 28, 2026 Sep 25, 2026
4 Insider transaction Sep 25, 2026 Sep 24, 2026
144 Notice of proposed sale Sep 24, 2026 —
4 Insider transaction Sep 22, 2026 Sep 21, 2026
144 Notice of proposed sale Sep 21, 2026 —
8-K Current report
Officer or director change
Sep 15, 2026 Sep 10, 2026
425 Filing Sep 8, 2026 —
8-K Current report
Other events
Sep 8, 2026 Sep 3, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
EFFECT Filing Sep 4, 2026 —
424B3 Prospectus Sep 4, 2026 —
144 Notice of proposed sale Sep 4, 2026 —
S-4/A Filing Sep 4, 2026 —
4 Insider transaction Sep 2, 2026 Mar 5, 2026
S-4 Registration for a merger or exchange Aug 25, 2026 —
4 Insider transaction Aug 21, 2026 Aug 20, 2026
144 Notice of proposed sale Aug 20, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
425 Filing Aug 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 31, 2026 —
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 28, 2026 Jul 28, 2026
425 Filing Jul 24, 2026 —
425 Filing Jul 22, 2026 —
425 Filing Jul 22, 2026 —
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
Jul 22, 2026 Jul 21, 2026
4 Insider transaction Jul 17, 2026 Jul 16, 2026
144 Notice of proposed sale Jul 16, 2026 —
4 Insider transaction Jun 26, 2026 Jun 25, 2026
144 Notice of proposed sale Jun 25, 2026 —
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
8-K Current report
Shareholder vote results
May 15, 2026 May 14, 2026
4 Insider transaction May 8, 2026 May 7, 2026
4 Insider transaction May 8, 2026 May 7, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
DEFA14A Additional proxy material Apr 27, 2026 —
4 Insider transaction Apr 22, 2026 Apr 21, 2026
144 Notice of proposed sale Apr 21, 2026 —
ARS Annual report to shareholders Apr 2, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 2, 2026 —
DEF 14A Proxy statement Apr 2, 2026 May 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 23, 2026 Mar 5, 2026
4 Insider transaction Mar 23, 2026 Mar 5, 2026
4 Insider transaction Mar 23, 2026 Mar 5, 2026
4 Insider transaction Mar 23, 2026 Mar 5, 2026
4 Insider transaction Mar 5, 2026 Mar 4, 2026
4 Insider transaction Mar 5, 2026 Mar 4, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Mar 2, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Mar 2, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 24, 2026 Feb 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2026 —
4 Insider transaction Jan 12, 2026 Dec 31, 2025
3 Initial insider ownership Jan 12, 2026 Dec 31, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 6, 2026 Jan 6, 2026
4 Insider transaction Dec 18, 2025 Dec 17, 2025
4 Insider transaction Dec 17, 2025 Dec 16, 2025
144 Notice of proposed sale Dec 17, 2025 —
4 Insider transaction Dec 8, 2025 Dec 4, 2025
4 Insider transaction Nov 26, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Nov 19, 2025 Nov 18, 2025
144 Notice of proposed sale Nov 18, 2025 —
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 13, 2025 Nov 12, 2025
144 Notice of proposed sale Nov 13, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 28, 2025 Oct 28, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Sep 26, 2025 Sep 25, 2025
4 Insider transaction Sep 11, 2025 Sep 10, 2025
144 Notice of proposed sale Sep 10, 2025 —
UPLOAD Letter from the SEC Sep 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 8, 2025 —
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 3, 2025
3 Initial insider ownership Sep 4, 2025 Sep 1, 2025
8-K Current report
Officer or director change
Sep 2, 2025 Sep 1, 2025
CORRESP Letter to the SEC Aug 26, 2025 —
UPLOAD Letter from the SEC Aug 14, 2025 —
4 Insider transaction Aug 12, 2025 Aug 8, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 29, 2025 Jul 29, 2025
4 Insider transaction May 21, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 16, 2025 May 15, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 15, 2025 May 15, 2025
144 Notice of proposed sale May 15, 2025 —
10-Q Quarterly report Apr 29, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 29, 2025 Apr 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 24, 2025 —
ARS Annual report to shareholders Apr 4, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 4, 2025 —
DEF 14A Proxy statement Apr 4, 2025 Apr 3, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
4 Insider transaction Mar 20, 2025 Mar 13, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
PRE 14A Preliminary proxy statement Mar 17, 2025 Mar 17, 2025
144 Notice of proposed sale Mar 17, 2025 —
10-K Annual report Mar 14, 2025 Dec 31, 2024
4 Insider transaction Mar 4, 2025 Mar 3, 2025
4 Insider transaction Mar 4, 2025 Mar 3, 2025
4 Insider transaction Mar 4, 2025 Mar 3, 2025
4 Insider transaction Mar 4, 2025 Mar 3, 2025
4 Insider transaction Mar 4, 2025 Mar 3, 2025
NT 10-K Filing Mar 3, 2025 Dec 31, 2024
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 28, 2025 Feb 27, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 25, 2025 Feb 24, 2025
8-K Current report
Results of operations
Feb 20, 2025 Feb 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
4 Insider transaction Dec 5, 2024 Dec 5, 2024
4 Insider transaction Nov 22, 2024 Nov 21, 2024
144 Notice of proposed sale Nov 21, 2024 —
4 Insider transaction Nov 21, 2024 Nov 20, 2024
4 Insider transaction Nov 21, 2024 Nov 20, 2024
4 Insider transaction Nov 20, 2024 Nov 19, 2024
10-Q Quarterly report Nov 18, 2024 Sep 30, 2024
10-Q/A Amended quarterly report Nov 18, 2024 Jun 30, 2024
10-Q/A Amended quarterly report Nov 18, 2024 Mar 31, 2024
10-K/A Amended annual report Nov 18, 2024 Dec 31, 2023
10-Q/A Amended quarterly report Nov 18, 2024 Sep 30, 2023
10-Q/A Amended quarterly report Nov 18, 2024 Jun 30, 2023
10-Q/A Amended quarterly report Nov 18, 2024 Mar 31, 2023
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
NT 10-Q Filing Nov 12, 2024 Sep 30, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure
Nov 12, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 23, 2024 —
8-K Current report
Results of operations, Restatement, Regulation FD disclosure
Sep 18, 2024 Sep 12, 2024
4 Insider transaction Sep 12, 2024 Sep 10, 2024
SC 13G/A Amended ownership over 5% (passive) Sep 10, 2024 —
144 Notice of proposed sale Sep 10, 2024 —
4 Insider transaction Sep 4, 2024 Sep 3, 2024
4 Insider transaction Sep 4, 2024 Sep 3, 2024
4/A Filing Aug 19, 2024 Jun 14, 2024
UPLOAD Letter from the SEC Aug 12, 2024 —
CORRESP Letter to the SEC Aug 6, 2024 —
4 Insider transaction Aug 5, 2024 Aug 2, 2024
144 Notice of proposed sale Aug 2, 2024 —
4 Insider transaction Aug 1, 2024 Aug 1, 2024
4 Insider transaction Aug 1, 2024 Aug 1, 2024
144 Notice of proposed sale Aug 1, 2024 —
144 Notice of proposed sale Aug 1, 2024 —
10-Q Quarterly report Jul 30, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 30, 2024 Jul 30, 2024
UPLOAD Letter from the SEC Jul 24, 2024 —
8-K Current report
Other events
Jul 15, 2024 Jul 15, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
4 Insider transaction Jun 14, 2024 Jun 14, 2024
8-K Current report
Officer or director change
Jun 14, 2024 Jun 12, 2024
8-K Current report
Regulation FD disclosure
Jun 13, 2024 Jun 13, 2024
4 Insider transaction May 22, 2024 May 21, 2024
144 Notice of proposed sale May 21, 2024 —
4 Insider transaction May 20, 2024 May 16, 2024
4 Insider transaction May 20, 2024 May 16, 2024
4 Insider transaction May 20, 2024 May 16, 2024
4 Insider transaction May 20, 2024 May 16, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
RGEN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
Large accelerated filer
SEC CIK
730272

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.